Shire plc (NASDAQ: SHPG) Stock Competitors & Peer Comparison
See SHPG's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Pharmaceuticals Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for SHPG and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| SHPG | $179.20 | +0.00% | 0 | 11.35 | $15.79 | +0.59% |
| RPRX | $57.97 | +2.11% | 25.7B | 11.04 | $5.25 | +1.58% |
| CORT | $114.23 | +3.12% | 12.3B | 326.37 | $0.35 | N/A |
| WBA | $11.98 | +0.50% | 10.4B | -1.64 | -$7.29 | +4.17% |
| LQDA | $91.03 | +0.90% | 8.1B | 650.21 | $0.14 | N/A |
| KNSA | $76.53 | +0.62% | 5.8B | 85.03 | $0.90 | N/A |
| TRLV | $9.08 | +3.77% | 1.5B | -21.50 | -$0.42 | N/A |
| HROWL | $25.61 | +0.19% | 1.4B | N/A | N/A | N/A |
| HROWM | $26.03 | -0.08% | 1.3B | N/A | N/A | N/A |
| LTGO | $18.56 | +1.70% | 1.1B | N/A | N/A | N/A |
Stock Comparison
Royalty Pharma plc (NASDAQ: RPRX)
SHPG vs RPRX Comparison August 2026
Shire plc (NASDAQ: SHPG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHPG stands at 0. In comparison, RPRX has a market cap of 25.7B. Regarding current trading prices, SHPG is priced at $179.20 on the NASDAQ, while RPRX trades at $57.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHPG currently has a P/E ratio of 11.35, whereas RPRX's P/E ratio is 11.04. In terms of profitability, SHPG's ROE is +0.13%, compared to RPRX's ROE of +0.12%. Regarding short-term risk, SHPG is less volatile compared to RPRX. This indicates lower risk in terms of short-term price fluctuations for SHPG.Check RPRX's competition here
Corcept Therapeutics Incorporated (NASDAQ: CORT)
SHPG vs CORT Comparison August 2026
Shire plc (NASDAQ: SHPG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHPG stands at 0. In comparison, CORT has a market cap of 12.3B. Regarding current trading prices, SHPG is priced at $179.20 on the NASDAQ, while CORT trades at $114.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHPG currently has a P/E ratio of 11.35, whereas CORT's P/E ratio is 326.37. In terms of profitability, SHPG's ROE is +0.13%, compared to CORT's ROE of +0.08%. Regarding short-term risk, SHPG is less volatile compared to CORT. This indicates lower risk in terms of short-term price fluctuations for SHPG.Check CORT's competition here
Walgreens Boots Alliance, Inc. (NASDAQ: WBA)
SHPG vs WBA Comparison August 2026
Shire plc (NASDAQ: SHPG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHPG stands at 0. In comparison, WBA has a market cap of 10.4B. Regarding current trading prices, SHPG is priced at $179.20 on the NASDAQ, while WBA trades at $11.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHPG currently has a P/E ratio of 11.35, whereas WBA's P/E ratio is -1.64. In terms of profitability, SHPG's ROE is +0.13%, compared to WBA's ROE of -0.42%. Regarding short-term risk, SHPG is similarly volatile compared to WBA. This indicates similar risk in terms of short-term price fluctuations for SHPG.Check WBA's competition here
Liquidia Corporation (NASDAQ: LQDA)
SHPG vs LQDA Comparison August 2026
Shire plc (NASDAQ: SHPG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHPG stands at 0. In comparison, LQDA has a market cap of 8.1B. Regarding current trading prices, SHPG is priced at $179.20 on the NASDAQ, while LQDA trades at $91.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHPG currently has a P/E ratio of 11.35, whereas LQDA's P/E ratio is 650.21. In terms of profitability, SHPG's ROE is +0.13%, compared to LQDA's ROE of +0.47%. Regarding short-term risk, SHPG is less volatile compared to LQDA. This indicates lower risk in terms of short-term price fluctuations for SHPG.Check LQDA's competition here
Kiniksa Pharmaceuticals International, plc (NASDAQ: KNSA)
SHPG vs KNSA Comparison August 2026
Shire plc (NASDAQ: SHPG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHPG stands at 0. In comparison, KNSA has a market cap of 5.8B. Regarding current trading prices, SHPG is priced at $179.20 on the NASDAQ, while KNSA trades at $76.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHPG currently has a P/E ratio of 11.35, whereas KNSA's P/E ratio is 85.03. In terms of profitability, SHPG's ROE is +0.13%, compared to KNSA's ROE of +0.14%. Regarding short-term risk, SHPG is less volatile compared to KNSA. This indicates lower risk in terms of short-term price fluctuations for SHPG.Check KNSA's competition here
Trulieve Cannabis Corp. (NYSE: TRLV)
SHPG vs TRLV Comparison August 2026
Shire plc (NASDAQ: SHPG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHPG stands at 0. In comparison, TRLV has a market cap of 1.5B. Regarding current trading prices, SHPG is priced at $179.20 on the NASDAQ, while TRLV trades at $9.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHPG currently has a P/E ratio of 11.35, whereas TRLV's P/E ratio is -21.50. In terms of profitability, SHPG's ROE is +0.13%, compared to TRLV's ROE of -0.44%. Regarding short-term risk, SHPG is less volatile compared to TRLV. This indicates lower risk in terms of short-term price fluctuations for SHPG.Check TRLV's competition here
Harrow Health, Inc. 8.625% Senior Notes due 2026 (NASDAQ: HROWL)
SHPG vs HROWL Comparison August 2026
Shire plc (NASDAQ: SHPG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHPG stands at 0. In comparison, HROWL has a market cap of 1.4B. Regarding current trading prices, SHPG is priced at $179.20 on the NASDAQ, while HROWL trades at $25.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHPG currently has a P/E ratio of 11.35, whereas HROWL's P/E ratio is N/A. In terms of profitability, SHPG's ROE is +0.13%, compared to HROWL's ROE of -0.34%. Regarding short-term risk, SHPG is less volatile compared to HROWL. This indicates lower risk in terms of short-term price fluctuations for SHPG.Check HROWL's competition here
Harrow Health, Inc. 11.875% Senior Notes due 2027 (NASDAQ: HROWM)
SHPG vs HROWM Comparison August 2026
Shire plc (NASDAQ: SHPG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHPG stands at 0. In comparison, HROWM has a market cap of 1.3B. Regarding current trading prices, SHPG is priced at $179.20 on the NASDAQ, while HROWM trades at $26.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHPG currently has a P/E ratio of 11.35, whereas HROWM's P/E ratio is N/A. In terms of profitability, SHPG's ROE is +0.13%, compared to HROWM's ROE of -0.34%. Regarding short-term risk, SHPG is less volatile compared to HROWM. This indicates lower risk in terms of short-term price fluctuations for SHPG.Check HROWM's competition here
Latigo Biotherapeutics Inc. (NASDAQ: LTGO)
SHPG vs LTGO Comparison August 2026
Shire plc (NASDAQ: SHPG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHPG stands at 0. In comparison, LTGO has a market cap of 1.1B. Regarding current trading prices, SHPG is priced at $179.20 on the NASDAQ, while LTGO trades at $18.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHPG currently has a P/E ratio of 11.35, whereas LTGO's P/E ratio is N/A. In terms of profitability, SHPG's ROE is +0.13%, compared to LTGO's ROE of N/A. Regarding short-term risk, SHPG is less volatile compared to LTGO. This indicates lower risk in terms of short-term price fluctuations for SHPG.Check LTGO's competition here
Clinuvel Pharmaceuticals Ltd. (NASDAQ: CUVL)
SHPG vs CUVL Comparison August 2026
Shire plc (NASDAQ: SHPG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHPG stands at 0. In comparison, CUVL has a market cap of 339.9M. Regarding current trading prices, SHPG is priced at $179.20 on the NASDAQ, while CUVL trades at $6.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHPG currently has a P/E ratio of 11.35, whereas CUVL's P/E ratio is N/A. In terms of profitability, SHPG's ROE is +0.13%, compared to CUVL's ROE of N/A. Regarding short-term risk, SHPG is similarly volatile compared to CUVL. This indicates similar risk in terms of short-term price fluctuations for SHPG.Check CUVL's competition here
LifeMD, Inc. (NASDAQ: LFMD)
SHPG vs LFMD Comparison August 2026
Shire plc (NASDAQ: SHPG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHPG stands at 0. In comparison, LFMD has a market cap of 175.1M. Regarding current trading prices, SHPG is priced at $179.20 on the NASDAQ, while LFMD trades at $3.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHPG currently has a P/E ratio of 11.35, whereas LFMD's P/E ratio is -7.24. In terms of profitability, SHPG's ROE is +0.13%, compared to LFMD's ROE of -1.79%. Regarding short-term risk, SHPG is less volatile compared to LFMD. This indicates lower risk in terms of short-term price fluctuations for SHPG.Check LFMD's competition here
LifeMD, Inc. (NASDAQ: LFMDP)
SHPG vs LFMDP Comparison August 2026
Shire plc (NASDAQ: SHPG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHPG stands at 0. In comparison, LFMDP has a market cap of 160.2M. Regarding current trading prices, SHPG is priced at $179.20 on the NASDAQ, while LFMDP trades at $23.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHPG currently has a P/E ratio of 11.35, whereas LFMDP's P/E ratio is -724.19. In terms of profitability, SHPG's ROE is +0.13%, compared to LFMDP's ROE of -1.79%. Regarding short-term risk, SHPG is similarly volatile compared to LFMDP. This indicates similar risk in terms of short-term price fluctuations for SHPG.Check LFMDP's competition here
Circle8 Group, Inc. (NASDAQ: CIRC)
SHPG vs CIRC Comparison August 2026
Shire plc (NASDAQ: SHPG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHPG stands at 0. In comparison, CIRC has a market cap of 63M. Regarding current trading prices, SHPG is priced at $179.20 on the NASDAQ, while CIRC trades at $0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHPG currently has a P/E ratio of 11.35, whereas CIRC's P/E ratio is -1.59. In terms of profitability, SHPG's ROE is +0.13%, compared to CIRC's ROE of +0.00%. Regarding short-term risk, SHPG is less volatile compared to CIRC. This indicates lower risk in terms of short-term price fluctuations for SHPG.Check CIRC's competition here
Rite Aid Corporation (NYSE: RAD)
SHPG vs RAD Comparison August 2026
Shire plc (NASDAQ: SHPG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHPG stands at 0. In comparison, RAD has a market cap of 36.8M. Regarding current trading prices, SHPG is priced at $179.20 on the NASDAQ, while RAD trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHPG currently has a P/E ratio of 11.35, whereas RAD's P/E ratio is -0.05. In terms of profitability, SHPG's ROE is +0.13%, compared to RAD's ROE of +2.76%. Regarding short-term risk, SHPG is less volatile compared to RAD. This indicates lower risk in terms of short-term price fluctuations for SHPG.Check RAD's competition here
Damora Therapeutics, Inc. (NASDAQ: GLTO)
SHPG vs GLTO Comparison August 2026
Shire plc (NASDAQ: SHPG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHPG stands at 0. In comparison, GLTO has a market cap of 34.5M. Regarding current trading prices, SHPG is priced at $179.20 on the NASDAQ, while GLTO trades at $21.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHPG currently has a P/E ratio of 11.35, whereas GLTO's P/E ratio is -1.78. In terms of profitability, SHPG's ROE is +0.13%, compared to GLTO's ROE of -1.22%. Regarding short-term risk, SHPG is less volatile compared to GLTO. This indicates lower risk in terms of short-term price fluctuations for SHPG.Check GLTO's competition here
SCYNEXIS, Inc. (NASDAQ: SCYX)
SHPG vs SCYX Comparison August 2026
Shire plc (NASDAQ: SHPG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHPG stands at 0. In comparison, SCYX has a market cap of 32.4M. Regarding current trading prices, SHPG is priced at $179.20 on the NASDAQ, while SCYX trades at $5.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHPG currently has a P/E ratio of 11.35, whereas SCYX's P/E ratio is -1.51. In terms of profitability, SHPG's ROE is +0.13%, compared to SCYX's ROE of -0.57%. Regarding short-term risk, SHPG is less volatile compared to SCYX. This indicates lower risk in terms of short-term price fluctuations for SHPG.Check SCYX's competition here
Nasus Pharma Ltd. (AMEX: NSRX)
SHPG vs NSRX Comparison August 2026
Shire plc (NASDAQ: SHPG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHPG stands at 0. In comparison, NSRX has a market cap of 29.4M. Regarding current trading prices, SHPG is priced at $179.20 on the NASDAQ, while NSRX trades at $3.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHPG currently has a P/E ratio of 11.35, whereas NSRX's P/E ratio is -4.74. In terms of profitability, SHPG's ROE is +0.13%, compared to NSRX's ROE of +0.00%. Regarding short-term risk, SHPG is less volatile compared to NSRX. This indicates lower risk in terms of short-term price fluctuations for SHPG.Check NSRX's competition here
Stablecoin Development Corp. (AMEX: SDEV)
SHPG vs SDEV Comparison August 2026
Shire plc (NASDAQ: SHPG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHPG stands at 0. In comparison, SDEV has a market cap of 27.6M. Regarding current trading prices, SHPG is priced at $179.20 on the NASDAQ, while SDEV trades at $1.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHPG currently has a P/E ratio of 11.35, whereas SDEV's P/E ratio is -0.18. In terms of profitability, SHPG's ROE is +0.13%, compared to SDEV's ROE of +7.90%. Regarding short-term risk, SHPG is less volatile compared to SDEV. This indicates lower risk in terms of short-term price fluctuations for SHPG.Check SDEV's competition here
Cerenome, Inc. (NASDAQ: CNSY)
SHPG vs CNSY Comparison August 2026
Shire plc (NASDAQ: SHPG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHPG stands at 0. In comparison, CNSY has a market cap of 26.4M. Regarding current trading prices, SHPG is priced at $179.20 on the NASDAQ, while CNSY trades at $3.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHPG currently has a P/E ratio of 11.35, whereas CNSY's P/E ratio is -0.53. In terms of profitability, SHPG's ROE is +0.13%, compared to CNSY's ROE of N/A. Regarding short-term risk, SHPG is less volatile compared to CNSY. This indicates lower risk in terms of short-term price fluctuations for SHPG.Check CNSY's competition here
Biofrontera Inc. (NASDAQ: BFRI)
SHPG vs BFRI Comparison August 2026
Shire plc (NASDAQ: SHPG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHPG stands at 0. In comparison, BFRI has a market cap of 15.5M. Regarding current trading prices, SHPG is priced at $179.20 on the NASDAQ, while BFRI trades at $1.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHPG currently has a P/E ratio of 11.35, whereas BFRI's P/E ratio is -1.13. In terms of profitability, SHPG's ROE is +0.13%, compared to BFRI's ROE of -4.77%. Regarding short-term risk, SHPG is less volatile compared to BFRI. This indicates lower risk in terms of short-term price fluctuations for SHPG.Check BFRI's competition here
China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD)
SHPG vs CJJD Comparison August 2026
Shire plc (NASDAQ: SHPG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHPG stands at 0. In comparison, CJJD has a market cap of 9.9M. Regarding current trading prices, SHPG is priced at $179.20 on the NASDAQ, while CJJD trades at $1.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHPG currently has a P/E ratio of 11.35, whereas CJJD's P/E ratio is -0.46. In terms of profitability, SHPG's ROE is +0.13%, compared to CJJD's ROE of -0.25%. Regarding short-term risk, SHPG is less volatile compared to CJJD. This indicates lower risk in terms of short-term price fluctuations for SHPG.Check CJJD's competition here
SunLink Health Systems, Inc. (AMEX: SSY)
SHPG vs SSY Comparison August 2026
Shire plc (NASDAQ: SHPG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHPG stands at 0. In comparison, SSY has a market cap of 7.9M. Regarding current trading prices, SHPG is priced at $179.20 on the NASDAQ, while SSY trades at $1.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHPG currently has a P/E ratio of 11.35, whereas SSY's P/E ratio is -2.86. In terms of profitability, SHPG's ROE is +0.13%, compared to SSY's ROE of -0.09%. Regarding short-term risk, SHPG is less volatile compared to SSY. This indicates lower risk in terms of short-term price fluctuations for SHPG.Check SSY's competition here
POMDOCTOR Ltd (NASDAQ: POM)
SHPG vs POM Comparison August 2026
Shire plc (NASDAQ: SHPG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHPG stands at 0. In comparison, POM has a market cap of 7.3M. Regarding current trading prices, SHPG is priced at $179.20 on the NASDAQ, while POM trades at $1.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHPG currently has a P/E ratio of 11.35, whereas POM's P/E ratio is -0.21. In terms of profitability, SHPG's ROE is +0.13%, compared to POM's ROE of +0.16%. Regarding short-term risk, SHPG is less volatile compared to POM. This indicates lower risk in terms of short-term price fluctuations for SHPG.Check POM's competition here
Paranovus Entertainment Technology Ltd. (NASDAQ: PAVS)
SHPG vs PAVS Comparison August 2026
Shire plc (NASDAQ: SHPG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHPG stands at 0. In comparison, PAVS has a market cap of 6.4M. Regarding current trading prices, SHPG is priced at $179.20 on the NASDAQ, while PAVS trades at $7.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHPG currently has a P/E ratio of 11.35, whereas PAVS's P/E ratio is -0.08. In terms of profitability, SHPG's ROE is +0.13%, compared to PAVS's ROE of -0.27%. Regarding short-term risk, SHPG is less volatile compared to PAVS. This indicates lower risk in terms of short-term price fluctuations for SHPG.Check PAVS's competition here
Cellyan Biotechnology Co., Ltd (NASDAQ: HKPD)
SHPG vs HKPD Comparison August 2026
Shire plc (NASDAQ: SHPG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHPG stands at 0. In comparison, HKPD has a market cap of 4.6M. Regarding current trading prices, SHPG is priced at $179.20 on the NASDAQ, while HKPD trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHPG currently has a P/E ratio of 11.35, whereas HKPD's P/E ratio is -6.99. In terms of profitability, SHPG's ROE is +0.13%, compared to HKPD's ROE of -0.14%. Regarding short-term risk, SHPG is less volatile compared to HKPD. This indicates lower risk in terms of short-term price fluctuations for SHPG.Check HKPD's competition here
AIxCrypto Holdings, Inc. (NASDAQ: AIXC)
SHPG vs AIXC Comparison August 2026
Shire plc (NASDAQ: SHPG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHPG stands at 0. In comparison, AIXC has a market cap of 4.1M. Regarding current trading prices, SHPG is priced at $179.20 on the NASDAQ, while AIXC trades at $0.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHPG currently has a P/E ratio of 11.35, whereas AIXC's P/E ratio is -0.09. In terms of profitability, SHPG's ROE is +0.13%, compared to AIXC's ROE of -0.94%. Regarding short-term risk, SHPG is less volatile compared to AIXC. This indicates lower risk in terms of short-term price fluctuations for SHPG.Check AIXC's competition here
MedAvail Holdings, Inc. (NASDAQ: MDVL)
SHPG vs MDVL Comparison August 2026
Shire plc (NASDAQ: SHPG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHPG stands at 0. In comparison, MDVL has a market cap of 2.9M. Regarding current trading prices, SHPG is priced at $179.20 on the NASDAQ, while MDVL trades at $1.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHPG currently has a P/E ratio of 11.35, whereas MDVL's P/E ratio is -0.05. In terms of profitability, SHPG's ROE is +0.13%, compared to MDVL's ROE of -2.39%. Regarding short-term risk, SHPG is less volatile compared to MDVL. This indicates lower risk in terms of short-term price fluctuations for SHPG.Check MDVL's competition here
ETHZilla Corporation Warrant (NASDAQ: ATNFW)
SHPG vs ATNFW Comparison August 2026
Shire plc (NASDAQ: SHPG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHPG stands at 0. In comparison, ATNFW has a market cap of 2.6M. Regarding current trading prices, SHPG is priced at $179.20 on the NASDAQ, while ATNFW trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHPG currently has a P/E ratio of 11.35, whereas ATNFW's P/E ratio is N/A. In terms of profitability, SHPG's ROE is +0.13%, compared to ATNFW's ROE of -2.41%. Regarding short-term risk, SHPG is less volatile compared to ATNFW. This indicates lower risk in terms of short-term price fluctuations for SHPG.Check ATNFW's competition here
Bio Green Med Solution, Inc. (NASDAQ: BGMSP)
SHPG vs BGMSP Comparison August 2026
Shire plc (NASDAQ: SHPG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHPG stands at 0. In comparison, BGMSP has a market cap of 2.4M. Regarding current trading prices, SHPG is priced at $179.20 on the NASDAQ, while BGMSP trades at $1.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHPG currently has a P/E ratio of 11.35, whereas BGMSP's P/E ratio is -0.84. In terms of profitability, SHPG's ROE is +0.13%, compared to BGMSP's ROE of -0.51%. Regarding short-term risk, SHPG is less volatile compared to BGMSP. This indicates lower risk in terms of short-term price fluctuations for SHPG.Check BGMSP's competition here
Bio Green Med Solution, Inc. (NASDAQ: BGMS)
SHPG vs BGMS Comparison August 2026
Shire plc (NASDAQ: SHPG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHPG stands at 0. In comparison, BGMS has a market cap of 2M. Regarding current trading prices, SHPG is priced at $179.20 on the NASDAQ, while BGMS trades at $0.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHPG currently has a P/E ratio of 11.35, whereas BGMS's P/E ratio is -0.25. In terms of profitability, SHPG's ROE is +0.13%, compared to BGMS's ROE of -0.51%. Regarding short-term risk, SHPG is less volatile compared to BGMS. This indicates lower risk in terms of short-term price fluctuations for SHPG.Check BGMS's competition here
AstraZeneca PLC ADRhedged (AMEX: AZNH)
SHPG vs AZNH Comparison August 2026
Shire plc (NASDAQ: SHPG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHPG stands at 0. In comparison, AZNH has a market cap of 1.6M. Regarding current trading prices, SHPG is priced at $179.20 on the NASDAQ, while AZNH trades at $53.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHPG currently has a P/E ratio of 11.35, whereas AZNH's P/E ratio is 38.35. In terms of profitability, SHPG's ROE is +0.13%, compared to AZNH's ROE of +0.00%. Regarding short-term risk, SHPG is less volatile compared to AZNH. This indicates lower risk in terms of short-term price fluctuations for SHPG.Check AZNH's competition here
Leafly Holdings, Inc. (NASDAQ: LFLYW)
SHPG vs LFLYW Comparison August 2026
Shire plc (NASDAQ: SHPG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHPG stands at 0. In comparison, LFLYW has a market cap of 299.9K. Regarding current trading prices, SHPG is priced at $179.20 on the NASDAQ, while LFLYW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHPG currently has a P/E ratio of 11.35, whereas LFLYW's P/E ratio is -0.00. In terms of profitability, SHPG's ROE is +0.13%, compared to LFLYW's ROE of +0.42%. Regarding short-term risk, SHPG is similarly volatile compared to LFLYW. This indicates similar risk in terms of short-term price fluctuations for SHPG.Check LFLYW's competition here
Sunshine Biopharma, Inc. (NASDAQ: SBFMW)
SHPG vs SBFMW Comparison August 2026
Shire plc (NASDAQ: SHPG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHPG stands at 0. In comparison, SBFMW has a market cap of 175.2K. Regarding current trading prices, SHPG is priced at $179.20 on the NASDAQ, while SBFMW trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHPG currently has a P/E ratio of 11.35, whereas SBFMW's P/E ratio is N/A. In terms of profitability, SHPG's ROE is +0.13%, compared to SBFMW's ROE of -0.26%. Regarding short-term risk, SHPG is less volatile compared to SBFMW. This indicates lower risk in terms of short-term price fluctuations for SHPG.Check SBFMW's competition here
Express Scripts Holding Company (NASDAQ: ESRX)
SHPG vs ESRX Comparison August 2026
Shire plc (NASDAQ: SHPG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHPG stands at 0. In comparison, ESRX has a market cap of 0. Regarding current trading prices, SHPG is priced at $179.20 on the NASDAQ, while ESRX trades at $92.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHPG currently has a P/E ratio of 11.35, whereas ESRX's P/E ratio is 10.69. In terms of profitability, SHPG's ROE is +0.13%, compared to ESRX's ROE of +0.26%. Regarding short-term risk, SHPG is similarly volatile compared to ESRX. This indicates similar risk in terms of short-term price fluctuations for SHPG.Check ESRX's competition here
POZEN Inc. (NASDAQ: POZN)
SHPG vs POZN Comparison August 2026
Shire plc (NASDAQ: SHPG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHPG stands at 0. In comparison, POZN has a market cap of 0. Regarding current trading prices, SHPG is priced at $179.20 on the NASDAQ, while POZN trades at $5.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHPG currently has a P/E ratio of 11.35, whereas POZN's P/E ratio is N/A. In terms of profitability, SHPG's ROE is +0.13%, compared to POZN's ROE of +0.61%. Regarding short-term risk, SHPG is less volatile compared to POZN. This indicates lower risk in terms of short-term price fluctuations for SHPG.Check POZN's competition here
Orexigen Therapeutics, Inc. (NASDAQ: OREX)
SHPG vs OREX Comparison August 2026
Shire plc (NASDAQ: SHPG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHPG stands at 0. In comparison, OREX has a market cap of 0. Regarding current trading prices, SHPG is priced at $179.20 on the NASDAQ, while OREX trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHPG currently has a P/E ratio of 11.35, whereas OREX's P/E ratio is -0.14. In terms of profitability, SHPG's ROE is +0.13%, compared to OREX's ROE of -0.54%. Regarding short-term risk, SHPG is less volatile compared to OREX. This indicates lower risk in terms of short-term price fluctuations for SHPG.Check OREX's competition here
Caraco Pharmaceutical Laboratories Ltd (AMEX: CPD)
SHPG vs CPD Comparison August 2026
Shire plc (NASDAQ: SHPG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHPG stands at 0. In comparison, CPD has a market cap of 0. Regarding current trading prices, SHPG is priced at $179.20 on the NASDAQ, while CPD trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHPG currently has a P/E ratio of 11.35, whereas CPD's P/E ratio is N/A. In terms of profitability, SHPG's ROE is +0.13%, compared to CPD's ROE of N/A. Regarding short-term risk, SHPG is less volatile compared to CPD. This indicates lower risk in terms of short-term price fluctuations for SHPG.Check CPD's competition here
Impax Laboratories, Inc. (NASDAQ: IPXL)
SHPG vs IPXL Comparison August 2026
Shire plc (NASDAQ: SHPG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHPG stands at 0. In comparison, IPXL has a market cap of 0. Regarding current trading prices, SHPG is priced at $179.20 on the NASDAQ, while IPXL trades at $18.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHPG currently has a P/E ratio of 11.35, whereas IPXL's P/E ratio is -10.11. In terms of profitability, SHPG's ROE is +0.13%, compared to IPXL's ROE of -1.16%. Regarding short-term risk, SHPG is less volatile compared to IPXL. This indicates lower risk in terms of short-term price fluctuations for SHPG.Check IPXL's competition here